𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibitory effect of drugs used in the treatment of Parkinson's disease on plasma monoamine oxidase activity

✍ Scribed by Helena Coelho; Maria Azevedo; C. Manso

Publisher
Springer
Year
1985
Tongue
English
Weight
252 KB
Volume
61
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The effect of drug treatment on neurogen
The effect of drug treatment on neurogenesis in Parkinson's disease
✍ Sean S. O'Sullivan; Mary Johnson; David R. Williams; Tamas Revesz; Janice L. Hol πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 176 KB

## Abstract There has been recent interest in the possibility that impaired neurogenesis may contribute to the decline in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease (PD). We have investigated the effects of commonly used treatments for PD on neural stem cell (NSC

A dose-ranging study of selegiline in pa
A dose-ranging study of selegiline in patients with Parkinson's disease: Effect on platelet monoamine oxidase activity
✍ Nathalie Andreu; Christine Damase-Michel; Jean-Michel Senard; Olivier Rascol; Pr πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 337 KB πŸ‘ 1 views

## Abstract A dose‐ranging study of selegiline was performed in patients with Parkinson's disease to determine the minimal dosage of the drug able to inhibit β‰₯95% of platelet monoamine oxidase (MAO) activity. Different doses of selegiline (5 or 10 mg daily, 10 or 20 mg weekly) were studied in four